EUVIMEDEUVIMED entdecken
Crossref

Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction

Hélène Le Ribeuz iD, Anaïs Saint-Martin Willer iD, Benoit Chevalier, Maria Sancho, Bastien Masson iD, Mélanie Eyries iD, Vincent Jung iD, Ida Chiara Guerrera iD, Mary Dutheil, Kristelle El Jekmek, Loann Laubry iD, Gilles Carpentier und 11 weitere

American Journal of Respiratory Cell and Molecular Biology · 2024

DOI: 10.1165/rcmb.2023-0185oc ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2024. Verfasst von Hélène Le Ribeuz und 22 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France. Hauptthemen laut MEDLINE: Dasatinib, Potassium Channels, Tandem Pore Domain, Endothelial Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial (PA) hypertension (PAH) is a severe cardiopulmonary disease that may be triggered by exposure to drugs such as dasatinib or facilitated by genetic predispositions. The incidence of dasatinib-associated PAH is estimated at 0.45%, suggesting individual predispositions. The mechanisms of dasatinib-associated PAH are still incomplete. We discovered a KCNK3 gene (Potassium channel subfamily K member 3; coding for outward K+ channel) variant in a patient with dasatinib-associated PAH and investigated the impact of this variant on KCNK3 function. Additionally, we assessed the effects of dasatinib exposure on KCNK3 expression. In control human PA smooth muscle cells (hPASMCs) and human pulmonary endothelial cells (hPECs), we evaluated the consequences of KCNK3 knockdown on cell migration, mitochondrial membrane potential, ATP production, and in vitro tube formation. Using mass spectrometry, we determined the KCNK3 interactome. Patch-clamp experiments revealed that the KCNK3 variant represents a loss-of-function variant. Dasatinib contributed to PA constriction by decreasing KCNK3 function and expression. In control hPASMCs, KCNK3 knockdown promotes mitochondrial membrane depolarization and glycolytic shift. Dasatinib exposure or KCNK3 knockdown reduced the number of caveolae in hPECs. Moreover, KCNK3 knockdown in control hPECs reduced migration, proliferation, and in vitro tubulogenesis. Using proximity labeling and mass spectrometry, we identified the KCNK3 interactome, revealing that KCNK3 interacts with various proteins across different cellular compartments. We identified a novel pathogenic variant in KCNK3 and showed that dasatinib downregulates KCNK3, emphasizing the relationship between dasatinib-associated PAH and KCNK3 dysfunction. We demonstrated that a loss of KCNK3-dependent signaling contributes to endothelial dysfunction in PAH and glycolytic switch of hPASMCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DasatinibPotassium Channels, Tandem Pore DomainEndothelial CellsHumansCell MovementPulmonary Arterial HypertensionMembrane Potential, MitochondrialMyocytes, Smooth MuscleMalePulmonary ArteryNerve Tissue Proteins

Stichwörter der Autor:innen

K2P3.1TASK-1TKIangiogenesiscaveolaeinteractomemitochondria

Substanzen

DasatinibPotassium Channels, Tandem Pore Domainpotassium channel subfamily K member 3Nerve Tissue Proteins

Autor:innen und Institutionen

  • Paris-Saclay University, Faculty of Medecine, Le Kremlin-Bicêtre, France.
  • INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Le Plessis-Robinson, France.
  • Paris Cité University, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris, France.
  • Department of Physiology and.
  • Department of Pharmacology, University of Vermont, Burlington, Vermont.
  • Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

ORCID-Profile: Hélène Le Ribeuz, Anaïs Saint-Martin Willer, Bastien Masson, Mélanie Eyries, Vincent Jung, Ida Chiara Guerrera, Loann Laubry, Francisco Perez-Vizcaino, Ly Tu, Christophe Guignabert, Marie-Camille Chaumais, Marc Humbert, Olaf Mercier, David Montani, Fabrice Antigny

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Ribeuz, H. L., Willer, A. S., Chevalier, B., Sancho, M., Masson, B., Eyries, M., Jung, V., Guerrera, I. C., Dutheil, M., Jekmek, K. E., Laubry, L., Carpentier, G., Perez-Vizcaino, F., Tu, L., Guignabert, C., Chaumais, M. C., Péchoux, C., Humbert, M., Hinzpeter, A., …, & Antigny, F. (2024). Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2023-0185oc

Vancouver

Ribeuz HL, Willer AS, Chevalier B, Sancho M, Masson B, Eyries M, et al. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 2024. doi:10.1165/rcmb.2023-0185oc

BibTeX
@article{Ribeuz2024,
  author = {Ribeuz, Hélène Le and Willer, Anaïs Saint-Martin and Chevalier, Benoit and Sancho, Maria and Masson, Bastien and Eyries, Mélanie and Jung, Vincent and Guerrera, Ida Chiara and Dutheil, Mary and Jekmek, Kristelle El and Laubry, Loann and Carpentier, Gilles and Perez-Vizcaino, Francisco and Tu, Ly and Guignabert, Christophe and Chaumais, Marie-Camille and Péchoux, Christine and Humbert, Marc and Hinzpeter, Alexandre and Mercier, Olaf and Capuano, Véronique and Montani, David and Antigny, Fabrice},
  title = {Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2024},
  doi = {10.1165/rcmb.2023-0185oc}
}
Kostenlos starten →